Frederick L. Weitl
Northern Illinois University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Frederick L. Weitl.
Radiation Research | 1984
Patricia W. Durbin; Nylan Jeung; Jones Es; Frederick L. Weitl; Kenneth N. Raymond
Macromolecules containing four sulfonated catecholy (2,3-dihydroxybenzoyl) groups are effective for decorporation of newly acquired Pu(IV). However, multiple injections in mice and single injections in dogs of 30 mumole/kg of 3,4,3-LICAM(S), the most effective sulfonated poly(catechoylamide) ligand, indicated that it would be toxic, so the ligand structure was modified. Each ligand was injected into mice (30 mumole/kg, intraperitoneally) 1 hr after an intravenous injection of 238Pu(IV) citrate, and mice were killed 24 hr after the Pu injection. Excreta and tissues were analyzed for Pu. (a) The number of catechoyl groups per molecule was reduced to suppress affinity for Fe(III). Net excretion (treated - control) of 55% of the injected Pu was promoted by tetrameric 3,4,3-LICAM(S), 51% by trimeric 3,4-LICAM(S), 22% by dimeric 2-LICAM(S), and 7.4% by the monomer, Tiron. (b) A mesitylene platform was substituted for the linear backbone. Net Pu excretion promoted by MECAM(S), a structurally less flexible trimer, was only 26%, and excretion was delayed. (c) A carboxyl substituent on the catechoyl groups reduced the acidity and hydrophilicity of the ligands. Tetrameric 3,4,3-LICAM(C) promoted 63% net Pu excretion, and one-third of that was fecal. The Pu contents of liver and skeleton were 33 and 44% of their respective 1-hr control values--compared to 51 and 44%, respectively, for CaNa3-DTPA. Mice given 30 mumole/kg of 3,4,3-LICAM(C) 20 times in 4 weeks showed no ill effects. (d) Large N-terminal alkane substituents added to 3,4,3-LICAM(C) increased ligand lipophilicity, hindered Pu chelation, and delayed excretion.
Journal of The Chemical Society, Chemical Communications | 1979
Wesley R. Harris; Frederick L. Weitl; Kenneth N. Raymond
The title compound, an analogue of the siderophore enterobactin, acts as a hexadentate ligand for FeIII ion, co-ordinating via the six phenolic oxygens to give a complex whose overall formation constant is 1045.8.
Journal of the American Chemical Society | 1981
Wesley R. Harris; Kenneth N. Raymond; Frederick L. Weitl
Journal of the American Chemical Society | 1979
Frederick L. Weitl; Kenneth N. Raymond
Journal of Organic Chemistry | 1990
Dennis N. Kevill; Jin Burm Kyong; Frederick L. Weitl
Journal of the American Chemical Society | 1980
Frederick L. Weitl; Kenneth N. Raymond
Journal of the American Chemical Society | 1970
Dennis N. Kevill; Kenneth C. Kolwyck; Frederick L. Weitl
Journal of Medicinal Chemistry | 1981
Frederick L. Weitl; Kenneth N. Raymond; Patricia W. Durbin
The Journal of Nuclear Medicine | 1981
Stephen M. Moerlein; Michael J. Welch; Kenneth N. Raymond; Frederick L. Weitl
Radiation Research | 1980
Patricia W. Durbin; E. Sarah Jones; Kenneth N. Raymond; Frederick L. Weitl